» Articles » PMID: 34610890

Characteristics of Electrolyte Imbalance and Pseudo-bartter Syndrome in Hospitalized Cystic Fibrosis Children and Adolescents

Overview
Journal J Cyst Fibros
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2021 Oct 6
PMID 34610890
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Pseudo-Bartter syndrome (PBS) is a rare manifestation of Cystic fibrosis (CF) and can often be the initial presentation in these patients, however, due to significantly overlapping symptoms it is often misdiagnosed as simple dehydration or Bartter syndrome. The objective of our study was to highlight the key features of PBS and electrolyte imbalance in CF patients helping in early and prompt diagnosis.

Method: We performed a retrospective study from January 2015 to December 2019 at the Aga Khan University Hospital (AKUH), Pakistan. CF patients aged from 1-18 years, admitted at AKUH were enrolled and their laboratory data and individual charts were reviewed. Patients were categorized into three groups based on their serum electrolyte profile and their clinical findings were compared.

Result: We enrolled 72 CF patients, out of which 42 (58%) were categorized into the Normal Electrolyte (NE) group, 19 (26%) into the Electrolyte Imbalance (EI) group and 11 (15%) in the PBS group. Out of 11 cases, 6 (54.54%) patients in PBS group presented with features consistent with PBS leading to CF diagnosis labeled as "early presenters". Mean age of patients in the PBS group was 3.81± 0.86 years and their age at diagnosis were significantly lower as compared to other groups. Gastrointestinal disturbances including diarrhea, vomiting and constipation were more common in the EI and PBS groups. Polyuria was most common in the PBS (72%) group. Length of hospital stay showed no significant difference.

Conclusion: Pseudo-Bartter syndrome can be a presenting feature of cystic fibrosis. Electrolyte imbalance should be anticipated in hospitalized CF children and adolescent.

Citing Articles

Diagnosis of cystic fibrosis: a high heterogeneity of symptoms and genotypes in a Brazil population.

Meneses D, Dos Santos F, Botelho A, Bispo L, Matos C, Propheta V BMC Pediatr. 2024; 24(1):422.

PMID: 38956483 PMC: 11218259. DOI: 10.1186/s12887-024-04891-z.


[Cystic fibrosis primarily presenting with pseudo-Bartter syndrome: a report of three cases and literature review].

Zhang J, Sun L, Duan X, Zhang Z, Xiao Z, Chen Y Zhongguo Dang Dai Er Ke Za Zhi. 2024; 26(5):506-511.

PMID: 38802912 PMC: 11135068. DOI: 10.7499/j.issn.1008-8830.2310080.


A year in review: Real world evidence, functional monitoring and emerging therapeutics in 2021.

Barr H, Bihouee T, Zwitserloot A J Cyst Fibros. 2022; 21(2):191-196.

PMID: 35272931 PMC: 8900606. DOI: 10.1016/j.jcf.2022.02.014.